, Tracking Stock Market Picks
Enter Symbol:

up 100.58 %

COVIDIEN LTD. COMMON SHARES (COV) rated Outperform by William Blair

Posted on: Tuesday,  Mar 13, 2012  11:25 AM ET by William Blair

William Blair rated Outperform COVIDIEN LTD. COMMON SHARES (NYSE: COV) on 03/13/2012, when the stock price was $53.20.
Since then, COVIDIEN LTD. COMMON SHARES has gained 100.58% as of 01/26/2016's recent price of $106.71.
If you would have followed this William Blair's recommendation on COV, you would have gained 100.58% of your investment in 1414 days.

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines, including Surgical Devices, Energy-Based Devices, Respiratory and Monitoring Solutions, Patient Care and Safety Products, Imaging Solutions, Pharmaceutical Products, Medical Supplies and Retail Products.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/13/2012 11:25 AM Buy
as of 12/31/2012
1 Week up  0.97 %
1 Month down  -0.63 %
3 Months down  -2.82 %
1 YTD up  8.53 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy